choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • CytRx Drugs

CytRx Drugs Newsletter
  • CytRx Corporation Relaunches as LadRx Corporation 23 Sep 2022 13:56 GMT

    … s next-gen LADR-based drugs, is built on the … events or otherwise. About CytRx CytRx Corporation CYTR is a biopharmaceutical … with cancer. CytRx's most recent advanced drug conjugate, … Inc. In addition, CytRx's drug candidate, arimoclomol, was sold …

  • CytRx Corporation Relaunches as LadRx Corporation 23 Sep 2022 13:47 GMT

    … next-gen LADR-based drugs, is built on the … future events or otherwise. About CytRx CytRx Corporation (OTCQB: CYTR) is … with cancer. CytRx’s most recent advanced drug conjugate, aldoxorubicin, … , Inc. In addition, CytRx’s drug candidate, arimoclomol, was sold …

  • StockNews.com Begins Coverage on CytRx (NASDAQ:CYTR) 18 Sep 2022 08:07 GMT

    … rating on the stock. CytRx Price Performance NASDAQ:CYTR opened … the quarter. About CytRx (Get Rating) CytRx Corporation, a biopharmaceutical … of novel anti-cancer drug candidates that employ novel … analysts' ratings for CytRx and related companies with …

  • European Patent Office Awards CytRx Key Patent 07 Sep 2022 13:49 GMT

    … CytRx has also pursued patent protection covering certain specific drugs … LADR system and of drugs incorporating the LADR system. … of LADR and the drugs that result from combining … ImmunityBio, Inc. In addition, CytRx’s drug candidate, arimoclomol, was sold …

  • CytRx Welcomes Cary J. Claiborne to the CytRx Board of Directors 09 Aug 2022 12:40 GMT

    … licensed drug Aldoxorubicin to the next-gen LADR drugs … events or otherwise. About CytRx CytRx Corporation (OTCQB: CYTR) … with cancer. CytRx’s most recent advanced drug conjugate, aldoxorubicin … Inc. In addition, CytRx’s drug candidate, arimoclomol, was sold …

  • CytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock 19 May 2022 21:23 GMT

    … uncertain and outside of CytRx’s control. Forward- … events or otherwise. About CytRx CytRx Corporation (OTCQB: CYTR) is … with cancer. CytRx’s most recent advanced drug conjugate, aldoxorubicin, … Inc. In addition, CytRx’s drug candidate, arimoclomol, was sold …

  • CytRx Highlights Strategic Purchase of Arimoclomol by KemPharm, Inc. 17 May 2022 12:30 GMT

    … , future events or otherwise. About CytRx CytRx Corporation (OTCQB: CYTR) is a … patients with cancer. CytRx’s most recent advanced drug conjugate, aldoxorubicin, is … ImmunityBio, Inc. In addition, CytRx’s drug candidate, arimoclomol, was sold to …

  • CytRx Partners with Oncology Development Expert to Advance LADR Platform 20 Apr 2022 12:15 GMT

    … developing its next-generation LADR drugs toward first-in-human clinical … next-generation LADR drugs closer to saving lives. CytRx is committed to … ImmunityBio, Inc. In addition, CytRx’s drug candidate, arimoclomol, was sold to …

  • CytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress 21 Mar 2022 12:00 GMT

    … lives by making cancer drugs work better with an … Our next-generation LADR drugs have undergone extensive testing and … our next-generation LADR drugs to human clinical trials. … ImmunityBio, Inc. In addition, CytRx’s drug candidate, arimoclomol, was sold …

  • CytRx Announces Integration of Wholly Owned Subsidiary Centurion BioPharma and Corporate Governance Updates 09 Mar 2022 13:00 GMT

    … lives by making cancer drugs work better with an … next-generation LADR drugs are now within CytRx and poised … pathways possible for the LADR drugs. Additionally, the Company expects … ImmunityBio, Inc. In addition, CytRx’s drug candidate, arimoclomol, was sold …

Satisfied with the content?

Continue to create your account.